Ocugen, Inc. insider trading
Every open-market purchase and sale by Ocugen, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
Insider purchases, 5 years $25,830 1 trade by 1 insider
3 months later: median −13.1% (−14.2% vs S&P 500) Insider sales, 5 years $1.1M 2 trades by 1 insider
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Ocugen, Inc.’s insiders pay?
From December 10, 2014 to June 17, 2026, 10 insiders reported 12 open-market purchases and 5 sales not made under a pre-set plan in Ocugen, Inc. After sales, the shares moved −67.8% against the index over 12 months (a negative figure means selling was the right call).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Zhang Junge | Director | 6 | — | — | 0 | — | June 16, 2023 |
| Castillo Kirsten | Director | 2 | — | — | 1 | — | November 26, 2024 |
| Fernandes Prabhavathi | Director | 0 | — | — | 1 | −72.8% (1) | May 27, 2021 |
| Gridley Adam | President and CEO | 1 | — | — | 0 | — | December 2, 2016 |
| Healy James | 10% owner | 0 | — | — | 1 | −73.9% (1) | December 10, 2014 |
| Intrexon Corp | 10% owner | 0 | — | — | 1 | — | January 15, 2019 |
| Johnson-Greene Treerita Essalima | Chief Financial Officer | 1 | — | — | 0 | — | June 17, 2026 |
| Musunuri Shankar | Chief Executive Officer | 1 | — | — | 0 | — | December 13, 2019 |
| Potti Manish | Director | 0 | — | — | 1 | −56.5% (1) | June 17, 2021 |
| Split Rock Partners II, LP | 10% owner | 1 | — | — | 0 | — | October 3, 2016 |